Highlights and Quick Summary
- Annual ROA for 2022 was -46.46% (a 7.37% increase from previous year)
- Annual ROA for 2021 was -43.27% (a 5909.72% increase from previous year)
- Annual ROA for 2020 was -0.72% (a -97.62% decrease from previous year)
- Twelve month ROA ending June 30, 2023 was -60.87% (a 15.88% increase compared to previous quarter)
- Twelve month trailing ROA increased by 58.93% year-over-year
Trailing ROA for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -60.87% | -52.53% | -46.46% | -38.3% |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROA of DURECT Corporation
Most recent ROAof DRRX including historical data for past 10 years.Interactive Chart of ROA of DURECT Corporation
DURECT Corporation ROA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -46.46% |
| 2021 | – | – | – | – | -43.27% |
| 2020 | – | – | – | – | -0.72% |
| 2019 | – | – | – | – | -30.26% |
| 2018 | – | – | – | – | -49.12% |
| 2017 | – | – | – | – | -7.89% |
| 2016 | – | – | – | – | -79.08% |
| 2015 | – | – | – | – | -46.8% |
| 2014 | – | – | – | – | -48.64% |
| 2013 | – | – | – | – | -49.45% |
| 2012 | – | – | – | – | 34.06% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic